Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleExperimental Studies

Nuclear Phospholipase C Signaling Through Type 1 IGF Receptor and its Involvement in Cell Growth and Differentiation

IRENE FAENZA, ANNA MARIA BILLI, MATILDE YUNG FOLLO, ROBERTA FIUME, ALBERTO MARIA MARTELLI, LUCIO COCCO and LUCIA MANZOLI
Anticancer Research May 2005, 25 (3B) 2039-2041;
IRENE FAENZA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA MARIA BILLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATILDE YUNG FOLLO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERTA FIUME
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALBERTO MARIA MARTELLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUCIO COCCO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lcocco{at}biocfarm.unibo.it
LUCIA MANZOLI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The existence of a nuclear polyphosphoinositol metabolism, independent from that at the plasma cell membrane, is now widely recognized. Specific changes in the nuclear phosphatidylinositol (PtdIns) metabolism have been implicated in cell growth, differentiation and neoplastic transformation. Here, the main features of nuclear inositol lipid signaling through type I IGF receptor, is reviewed with particular attention to the role of inositide-specific phospholipase C (PI-PLC),1 in cell proliferation and differentiation, due to the peculiar localization of this molecule in the nuclear compartment.

  • Phospholipase C
  • signaling
  • nucleus

Footnotes

  • Received December 23, 2004.
  • Accepted April 5, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 3B
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear Phospholipase C Signaling Through Type 1 IGF Receptor and its Involvement in Cell Growth and Differentiation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nuclear Phospholipase C Signaling Through Type 1 IGF Receptor and its Involvement in Cell Growth and Differentiation
IRENE FAENZA, ANNA MARIA BILLI, MATILDE YUNG FOLLO, ROBERTA FIUME, ALBERTO MARIA MARTELLI, LUCIO COCCO, LUCIA MANZOLI
Anticancer Research May 2005, 25 (3B) 2039-2041;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nuclear Phospholipase C Signaling Through Type 1 IGF Receptor and its Involvement in Cell Growth and Differentiation
IRENE FAENZA, ANNA MARIA BILLI, MATILDE YUNG FOLLO, ROBERTA FIUME, ALBERTO MARIA MARTELLI, LUCIO COCCO, LUCIA MANZOLI
Anticancer Research May 2005, 25 (3B) 2039-2041;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • 40 YEARS OF IGF1: IGF1 receptor signaling pathways
  • Phosphoinositide-specific phospholipase C in health and disease
  • Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1-Risk Myelodysplastic Syndromes
  • Google Scholar

More in this TOC Section

  • POM121 Drives Gastric Cancer Progression via the mTOR/p70S6K Signaling Axis
  • Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine Dependence
  • mTOR Modulation Affects Galectin-1 Expression in KMT2A-rearranged Acute Lymphoblastic Leukemia Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire